Summit Securities Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-239,000
Closed -$24.7M 1149
2021
Q4
$24.7M Buy
239,000
+238,726
+87,126% +$22.1M 1.15% 11
2021
Q3
$2.33M Sell
274
-81
-23% -$6.79K 0.18% 133
2021
Q2
$2.96M Buy
355
+55
+18% +$4.5K 0.25% 92
2021
Q1
$2.26M Buy
+300
New +$21.9K 0.25% 84
2019
Q2
Sell
-635
Closed -$3.42M 333
2019
Q1
$3.42M Hold
635
0.63% 33
2018
Q4
$4.16M Buy
+635
New +$47.4K 0.36% 46

Other funds holding CVS

Summit Securities Group's CVS Position: Q2 2026 in Review

Summit Securities Group reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $10.1K and leaving 896 shares worth $92.7K. The position accounts for 0.01% of the portfolio, ranked #423.

Summit Securities Group first reported a position in CVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $10.1M in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Summit Securities Group held 896 shares of CVS Health worth $92.7K as of Q2 2026.
  • Summit Securities Group sold 113 CVS Health shares in Q2 2026, an estimated $10.1K.
  • CVS Health made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #423 holding.
  • Summit Securities Group first reported a position in CVS Health in Q2 2013 and has held it in 39 quarters since.
  • Summit Securities Group's CVS Health position peaked at $10.1M in Q4 2021.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.